To commemorate this year’s World Sickle Cell Day, on 19th June, ERN-EuroBloodNet have put the spotlight on the European research and education initiatives fighting to improve the lives of individuals and families affected by this condition. We are very proud to see GenoMed4All listed alongside other EU-funded initiatives including EVIDENCE, INHERENT, EDITSCD and our sister project SYNTHEMA in this interactive poster created by ERN-EuroBloodNet to mark the occasion.

Mar Mañú Pereira, Principal Investigator at our partner institution Vall d’Hebron Institute of Research (VHIR), also introduced the work carried out by GenoMed4All’s consortium and the other four projects during a presentation to the Sickle Cell Disease Spanish Association (ASAFE) earlier this week, coinciding with ERN-EuroBloodNet’s campaign in celebration of World Sickle Cell Day 2023.

According to the Global Alliance of Sickle Cell Disease Organizations (GASCDO), one of this year’s themes is dedicated to raising awareness about the latest technological advancements in the SCD field, helping patients and healthcare professionals to identify the current status of the disease. The partners involved in GenoMed4All believe that technology, especially Artificial Intelligence, holds the power to bring new and improved diagnosis and prognosis into the future of healthcare, which in turn will positively contribute to the future of those suffering from rare haematological diseases, such as Sickle Cell.

Read more about our mission to empower forward-thinking research of common and rare Haematological Diseases.